<unk>  is a radiolabeled somatostatin analog that is FDA approved for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and handgun neuroendocrine tumors in adults.   Common adverse reactions include lymphopenia, increased GGT, vomiting, nausea, increased AST, increased ALT, hyperglycemia and hypokalemia.
Lutetium lu 177 dotatate
Lutetium Lu 177 dotatate
Bromo-DragonFLY
Thallous Chloride Tl 201
Diodone
Gallium Citrate Ga 67
Technetium 
Liothyronine sodium